Monitoring of PD-L1 expression on circulating immune cells of patients with small cell lung cancer (SCLC) receiving firstline treatment: Prognostic implications

被引：1
|
作者：
Papadaki, M. A. [1 ]
Nikolarakou, M-N. [1 ]
Vorrias, E. [2 ]
Kapetanaki, E-E. [1 ]
Kalapanida, D. [2 ]
Mavroudis, D. [2 ]
Agelaki, S. [2 ]
机构：
[1] UOC Univ Crete, Sch Med, Lab Translat Oncol, Iraklion, Greece
[2] Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion, Greece
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.02.181
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
150P
引用
收藏
页码：S101 / S101
页数：1
相关论文
共 50 条
  • [21] Method development for detection of PD-L1 in circulating tumor cells in small-cell lung cancer patients
    Cheng, Ying
    Li, Hui
    Zhao, Dandan
    Liu, Yan
    Wang, Ying
    Liu, Xianhong
    Cui, Hongxia
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab
    Nicolazzo, Chiara
    Raimondi, Cristina
    Mancini, MariaLaura
    Caponnetto, Salvatore
    Gradilone, Angela
    Gandini, Orietta
    Mastromartino, Maria
    del Bene, Gabriella
    Prete, Alessandra
    Longo, Flavia
    Cortesi, Enrico
    Gazzaniga, Paola
    SCIENTIFIC REPORTS, 2016, 6
  • [23] Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab
    Chiara Nicolazzo
    Cristina Raimondi
    MariaLaura Mancini
    Salvatore Caponnetto
    Angela Gradilone
    Orietta Gandini
    Maria Mastromartino
    Gabriella del Bene
    Alessandra Prete
    Flavia Longo
    Enrico Cortesi
    Paola Gazzaniga
    Scientific Reports, 6
  • [24] Longitudinal Evaluation of PD-L1 Expression on Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients Treated with Nivolumab
    Ikeda, Mio
    Koh, Yasuhiro
    Teraoka, Shunsuke
    Sato, Koichi
    Oyanagi, Jun
    Hayata, Atsushi
    Tokudome, Nahomi
    Akamatsu, Hiroaki
    Ozawa, Yuichi
    Endo, Katsuya
    Higuchi, Masayuki
    Nakanishi, Masanori
    Ueda, Hiroki
    Yamamoto, Nobuyuki
    CANCERS, 2021, 13 (10)
  • [25] Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer
    Kallergi, Galatea
    Vetsika, Eleni-Kyriaki
    Aggouraki, Despoina
    Lagoudaki, Eleni
    Koutsopoulos, Anastasios
    Koinis, Filippos
    Katsarlinos, Panagiotis
    Trypaki, Maria
    Messaritakis, Ippokratis
    Stournaras, Christos
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
  • [26] Significance of the Expression of PD-L1/PD-1 by Tumoral and Immune Cells in Non-Small Cell Lung Cancer.
    Ortiz-Villalon, C.
    De Petris, L.
    Kis, L.
    Yoshikawa, A.
    Ngoc, H.
    Roden, A.
    Fukuoka, J.
    Montero, A.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S948 - S948
  • [27] Basal Circulating Leukocyte-Platelet Complexes and PD-L1 Expression on Circulating Cells in Patients with Advanced SCLC
    Piedra, A.
    Guinart-Cuadra, A.
    Mulet, M.
    Zamora, C.
    Alejandre, J.
    Martinez-Recio, S.
    Barba, A.
    Sullivan, I.
    Serra-Lopez, J.
    Isla, D.
    Arriola, E.
    Paz-Ares, L.
    Diz, M. P.
    Moreno, A. L.
    Callejo, A.
    Vidal, S.
    Majem, M.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S355 - S355
  • [28] Differential expression of PD-L1 on circulating tumor cells among patients with advanced lung cancer
    Kim, Woong
    Koh, Yasuhiro
    Akamatsu, Hiroaki
    Yagi, Satomi
    Tanaka, Ayaka
    Kanai, Kuninobu
    Hayata, Atsushi
    Shibaki, Ryota
    Higuchi, Masayuki
    Kanbara, Hisashige
    Kikuchi, Takashi
    Akamatsu, Keiichiro
    Nakanishi, Masanori
    Ueda, Hiroki
    Yamamoto, Nobuyuki
    CANCER RESEARCH, 2016, 76
  • [29] Prognostic implications of PD-L1 expression in patients with angiosarcoma
    Lee, Jii Bum
    Ahn, Beung-Chul
    Kim, Seung Hyun
    Lee, Young Han
    Han, Jung Woo
    Jeon, Min Kyung
    Kim, Soo Hee
    Kim, Hyo Song
    FUTURE SCIENCE OA, 2021, 7 (05):
  • [30] Assessment of PD-L1 Expression on Circulating Tumor Cells for Predicting Clinical Outcomes in Patients with Cancer Receiving PD-1/PD-L1 Blockade Therapies
    Tan, Zhaoli
    Yue, Chunyan
    Ji, Shoujian
    Zhao, Chuanhua
    Jia, Ru
    Zhang, Yun
    Liu, Rongrui
    Li, Da
    Yu, Qian
    Li, Ping
    Hu, Zhiyuan
    Yang, Yanlian
    Xu, Jianming
    ONCOLOGIST, 2021, : e2227 - e2238
12345